Literature DB >> 11815766

Prevalence and specificity of antigastric autoantibodies in adolescents infected with Helicobacter pylori.

Gerhard Faller1, Klaus-Michael Keller, Dirk Claeys, Stephan Buderus, Doris Kühlwein, Nicole Reiche, Thomas Kirchner.   

Abstract

OBJECTIVES: Antigastric autoantibodies (AGA) can be detected in as many as 50% of adults infected with Helicobacter pylori. We investigated H pylori -associated antigastric autoimmunity in children and adolescents. STUDY
DESIGN: Patients with dyspepsia (n = 78; mean age 10.9 years, range 2-21 years, SE 0.46 years) underwent gastroscopy. H pylori infection was determined by serologic and histologic features and breath tests. AGA were detected by immunohistochemistry and were characterized by immunoprecipitation with the gastric hydrogen ion, potassium ion, adenosine triphosphatase (H(+),K(+)-ATPase). In absorption assays, antibodies against H pylori were removed to determine the role of molecular mimicry.
RESULTS: AGA were detected in 9 (18%) of the 51 infected patients and in 1 (4 %) of the 27 noninfected patients (P =.08; nonsignificant) and could not be absorbed to H pylori. Children with AGA were significantly older (P =.01). AGA in H pylori gastritis reacted against the gastric H(+),K(+)-ATPase in 3 (33%) of the 9 patients.
CONCLUSIONS: The age of the patient or the duration of gastritis seem to be relevant factors for the formation of antigastric autoimmunity. The gastric H(+),K(+)-ATPase represents an autoantigen as early as childhood. No evidence for a role of molecular mimicry between H pylori and the host at this young age could be found.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815766     DOI: 10.1067/mpd.2002.120270

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  1 in total

1.  Bacterial peptides are intensively present throughout the human proteome.

Authors:  Brett Trost; Anthony Kusalik; Guglielmo Lucchese; Darja Kanduc
Journal:  Self Nonself       Date:  2010-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.